DASI Simulations
Category: AI in Healthcare
An AI-powered platform that provides patient-specific predictive modeling for structural heart procedures to improve outcomes and reduce complications. DASI Simulations was founded in 2019. The company is led by Teri Sirset. Based in Dublin, Ohio, USA. Team size: 37. Total funding raised: $11.5M. Latest round: Venture Round. Key investors include Rev1 Ventures, MedTech Innovator, Ohio Third Frontier, K2X, TiE Women, Accelerating Angels.
- Founded
- 2019
- Headquarters
- Dublin, Ohio, USA
- Team size
- 37
- Total funding
- $11.5M
Value proposition
AI-generated guidance for data-driven clinical decisions for personalized heart procedures, improving outcomes and reducing costs.
Products and solutions
Precision TAVI, Dasi Dimensions
Unique value
Ability to use AI to create a 'digital twin' of a patient's heart, allowing predictive simulations of procedures.
Target customer
Hospitals, heart teams, surgeons, and medical device companies involved in structural heart care.
Industries served
Healthcare, Medical Devices, Structural Heart Care
Technology advantage
Proprietary AI-driven simulation technology that shifts procedures from reactive to predictive.
How they differentiate
Focus on pre-procedural predictive planning for structural heart interventions, not diagnostics or manufacturing replacements.
Main competitors
HeartFlow, Foldax, CathVision
Key partnerships
MedTech Innovator (Accelerator Program), Rev1 Ventures, Ohio Third Frontier, University Hospitals (Live Case Collaboration), Cleveland Clinic (Co-development partnership, Oct 2025), Medtronic (Strategic partnership, Oct 2025)
Notable customers
University Hospitals, Cleveland Clinic, Sentara Heart Hospital, Tucson Medical Center, Stanford Medical Center, plus 35+ health systems across the U.S.
Major milestones
Received FDA clearance for Precision TAVI (May 2023) Closed $5M funding round (February 2024) Selected for MedTech Innovator Accelerator Program (2023) Closed $5M Venture Round with Cedars-Sinai Health Ventures & Georgia Tech VentureLab (June 2025) Finalized 11 commercial agreements across 7 states (June 2025) Cleveland Clinic co-development partnership for AI 'co-pilot' (Oct 2025) Medtronic strategic partnership for TAVR (Oct 2025)
Growth metrics
Signed 35 health systems to software subscriptions as of mid-2025, with 20+ in final contracting and 50+ in earlier negotiation stages.
Market positioning
A pioneering technology provider in AI-driven surgical planning.
Geographic focus
Primarily the United States market.
Patents and IP
The company has 6 patents filed for its technology.
About Teri Sirset
Teri Sirset is the Co-founder & CEO of DASI Simulations, a medical technology start-up located in Columbus Ohio. She has a passion for improving patient outcomes, born out of her father’s very difficult journey as he struggled with heart disease. Her goal is to build a company that will have a lasting impact on medicine and to create a new standard of care for all patients.
Official website: https://dasisim.ai/